Early Detection of Chronic Kidney Disease

NCT06950151 | Completed

• 1 other identifier: CSAPG-72
• Study Type: observational
• Target: 345
• Locations: 1 country
• Sites: 1

Brief Summary

This retrospective observational study aims to assess the proportion of patients who were appropriately referred from primary care to the nephrology teleconsultation service. The appropriateness of the referral will be determined by the time elapsed between the referral criteria being met and the date of the teleconsultation, as well as by the patient's treatment at the time of referral.

Conditions

Chronic Kidney Diseases

Outcome Measures

Primary Outcomes (1)

• Appropriate referral to teleconsultation

  Proportion of patients referred to nephrology teleconsultation during 2024 in a timely manner and with appropriate treatment. Timely referral is defined as referral within three months of the appearance of nephrology referral criteria. Treatment adequacy will be assessed based on the recommendations of the SEMERGEN Primary Care guidelines and the therapeutic harmonization protocols established by CatSalut.

  Baseline

Study Arms (1)

Chronic Kidney Disease Group

Patients with chronic kidney disease and at least one referral criterion for nephrology teleconsultation.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients with chronic kidney disease who are referred to nephrology teleconsultation from primary care

You may qualify if:

• Men and women over 18 years of age
• Teleconsultation to nephrology from Primary Care in the Garraf region during the period from January to December 2024
• Patients with at least one referral criterion for the nephrology service

You may not qualify if:

• Participants diagnosed with any of the following conditions:
• Patients with Chronic Kidney Disease previously evaluated by the nephrology service.
• History of requiring renal replacement therapy (hemodialysis, peritoneal dialysis, or kidney transplantation).
• Patients hospitalized within the last 3 months with a diagnosis of kidney failure.
• Patients with a known prior diagnosis of Autosomal Dominant Polycystic Kidney Disease or glomerular diseases.

Sponsors & Collaborators

• Consorci Sanitari de l'Alt Penedès i Garraf: lead

Study Sites (1)

Consorci Sanitari Alt Penedés-Garraf

Sant Pere de Ribes, Barcelona, 08810, Spain

Location

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Ignacio Manzur, MD

  CSAPG

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 22, 2025
• First Posted: April 30, 2025
• Study Start: April 22, 2025
• Primary Completion: October 16, 2025
• Study Completion: October 16, 2025
• Last Updated: December 2, 2025

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: After publication of main results of the study.
• Access Criteria: IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.

Locations

ES (1)